Pharmacokinetics of eribulin mesylate in cancer patients with normal and impaired renal function

2595 Background: Eribulin mesylate is a novel microtubule dynamics inhibitor. The effect of renal impairment on eribulin PK was evaluated following a single dose in adult pts with advanced solid tu...